Financhill
Back

CytomX Therapeutics Quote, Financials, Valuation and Earnings

CytomX Therapeutics Price Quote

$5.10
+3.47 (+211.93%)
(Updated: May 1, 2024 at 6:55 PM ET)

CytomX Therapeutics Key Stats

Sell
16
CytomX Therapeutics (CTMX) is a Sell

Day range:
$1.59 - $1.66
52-week range:
$1.04 - $2.86
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.19
P/B ratio:
0%

Volume:
329.6K
Avg. volume:
591.8K
1-year change:
0.31%
Market cap:
$110.7M
Revenue:
$101.2M
EPS:
$-0.02

How Much Does CytomX Therapeutics Make?

Is CytomX Therapeutics Growing As A Company?

  • What Is CytomX Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.32%
  • What Is CytomX Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

CytomX Therapeutics Stock Price Performance

What Is CytomX Therapeutics 52-Week High & Low?

CytomX Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CytomX Therapeutics?

Is CytomX Therapeutics Cash Flow Positive?

  • What Is CTMX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$56M
  • What Is CytomX Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.2M
  • What Is CytomX Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$150.7M

CytomX Therapeutics Return On Invested Capital

Data Unavailable

CytomX Therapeutics Earnings Date & Stock Price

CytomX Therapeutics Competitors

  • Who Are CytomX Therapeutics's Competitors?
    Below is a list of companies who compete with CytomX Therapeutics or are related in some way:
    • ACADIA Pharmaceuticals Inc (ACAD)
    • Bristol-Myers Squibb Co (BMY)
    • Calidi Biotherapeutics Inc (CLDI)
    • Cytokinetics Inc (CYTK)
    • Ocular Therapeutix Inc (OCUL)

CytomX Therapeutics Dividend Yield

Data Unavailable

CytomX Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 135.09%
Revenue: 32.22% 25.41%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 2.90
Upside from Last Price: 77.37%

Major Shareholders

  • How many CTMX shares are owned by institutional investors?
    48.6M CTMX shares are owned by institutional investors
  • How many CTMX shares are owned by insiders?
    1.7M CTMX shares are owned by insiders